Cipla gets final nod for generic therapeutic equivalent of Tecfidera; stock opens 1.52 per cent higher
Cipla gets final nod for generic therapeutic equivalent of Tecfidera; stock opens 1.52 per cent higher

Cipla gets final nod for generic therapeutic equivalent of Tecfidera; stock opens 1.52 per cent higher

Rishikesh Gaikwad Article rating: 3.4

Cipla Limited today announced that it has received final approval for its abbreviated new drug application (ANDA) for Dimethyl Fumarate DR Capsules 120mg, 240mg, and 120mg/240mg starter pack from United States Food & Drug Administration (USFDA).

Nifty trend and stocks in action on September 25, 2020
Nifty trend and stocks in action on September 25, 2020

Nifty trend and stocks in action on September 25, 2020

Karan Dsij Article rating: 4.7

The onus is on the 200-DMA, which is placed at 10,761. If bulls manage to defend it, expect a pullback up to the levels of 10,980, or else, 10,640-10,550 is the next destination. Stocks in news: Cipla, GMR Infrastructure, ONGC, GAIL, RITES, TCS.

Start your day with smile as SGX Nifty indicates a positive opening!
Start your day with smile as SGX Nifty indicates a positive opening!

Start your day with smile as SGX Nifty indicates a positive opening!

Karan Dsij Article rating: 4.8

The Indian markets are gripped by three key factors namely, fear, uncertainty, and doubt. The fear is rising as it is quite evident from the surge in India VIX. Uncertainty is hovering over as some countries are planning another lockdown to combat the spread of Coronavirus and doubt over the pace of economic recovery.

India INX catches global traders' attention, assists GIFT City to become next global financial hub!
India INX catches global traders' attention, assists GIFT City to become next global financial hub!

India INX catches global traders' attention, assists GIFT City to become next global financial hub!

Geyatee Deshpande Article rating: 4.3

As of now BSE's flagship index – Sensex 50 is traded on India International Exchange (India INX) and is catching trader's attention. The total turnover on the India INX is increasing steadily and has reached USD 57.7 billion in August 2020, with a market share of 57 per cent against comparable index in Singapore. There are as many as 100 proprietary traders active on the exchange and more than 40 members are currently active with more members awaiting the regulatory approvals.

Havells India enters into refrigerator space via Lloyd brand
Havells India enters into refrigerator space via Lloyd brand

Havells India enters into refrigerator space via Lloyd brand

Anthony Fernandes Article rating: 4.0

The leading fastā€moving electrical goods (FMEG) company, Havells India Limited, informed the bourses on Thursday that it has entered into the refrigerator segment under its consumer durable brand-Lloyd.

Zydus Cadila receives nod to market anti-cancer medicine
Zydus Cadila receives nod to market anti-cancer medicine

Zydus Cadila receives nod to market anti-cancer medicine

Chinmayee D Article rating: 3.7

Zydus Cadila is said to market Palbociclib capsules (US RLD: Ibrance capsules) in the strengths of 75 mg, 100 mg, and 125 mg. The drug interferes with the growth and spread of cancer cells in the body.

Tata Elxsi opens Global Engineering Centre with Schaeffler Technologies
Tata Elxsi opens Global Engineering Centre with Schaeffler Technologies

Tata Elxsi opens Global Engineering Centre with Schaeffler Technologies

Rishikesh Gaikwad Article rating: 3.8

Tata Elxsi, a global design and technology services company, announced the opening of a Global Engineering Centre (GEC) with Schaeffler Technologies AG & Co. KG, a world leader in providing mechatronics solutions for the transportation industry. Schaeffler Group is a global supplier to the automotive and industrial sectors.

RSS
First24072408240924102412241424152416Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR